ARCHIVES

Two-Year Remission While Taking Gleevec Puts Patients Into Normal Mortality Rate

This article is from The Cancer Letter archive.

Vol. 34 No. 3 | March 25, 2011

Download PDF Visit The Full Archive

Related Articles

FDA Proposes To Drop Specific Requirements For Reprint Distribution On Off-Label Uses.

February 22, 2008

DeVita Considers Alternatives to Recommendation Of NCAB On Organ Systems Coordinating Center

June 1, 1984

Trials Suspended At Oklahoma Over Study Of Cancer Vaccine.

July 14, 2000

In Brief: No End Of The Year Hassle His Time – NCI Full Appropriation for FY 1977 Released

November 19, 1976

Mothers’ Smoking, Depression Influences Teen Smoking

May 28, 2010

NIEHS Conference to Look At 21st Century Issues

April 1, 1988